Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Xinran Biotechnology is a biotechnology firm based in Guangzhou, China, that leverages synthetic biology to develop high-performance bio-based materials. The company specializes in the production of recombinant humanized collagen, which is utilized in medical aesthetics, dermatology, and wound care applications. By utilizing advanced microbial fermentation and protein purification technologies, Xinran Biotech produces collagen with high bioactivity and safety profiles for use in medical devices and functional cosmetics. Their product portfolio includes medical-grade skin repair dressings and raw materials for the global beauty and healthcare industries. The company aims to replace traditional animal-derived collagen with sustainable, high-purity synthetic alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Xinran Biotechnology.